日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Analysis of Prognostic Factors for Internal Carotid Artery Invasion by Nasopharyngeal Carcinoma

鼻咽癌侵犯颈内动脉预后因素分析

Lien, Ching-Feng; Yeh, Shyh-An; Cheng, Chiu-Shih; Chiang, Feng-Yu; Hwang, Tzer-Zen; Cai, Bi-He; Liu, Chih-Yi; Weng, Hsu-Huei; Chen, Chia-Chi; Hsieh, Meng-Che

Strategies for Anticancer Treatment in p53-Mutated Head and Neck Squamous Cell Carcinoma

p53突变型头颈部鳞状细胞癌的抗癌治疗策略

Cai, Bi-He; Chen, Chia-Chi; Sung, Yu-Te; Shih, Yu-Chen; Lien, Ching-Feng

Synergistic Anticancer Activity of HSP70 Inhibitor and Doxorubicin in Gain-of-Function Mutated p53 Breast Cancer Cells

HSP70抑制剂与阿霉素在功能获得性突变p53乳腺癌细胞中的协同抗癌活性

Wu, Kuan-Yo; Crucho, Ana; Su, Mia; Chen, Sih-Tong; Hung, Chen-Hsiu; Kou, Yu-Ling; Liu, Yu-Jie; Hsu, Tzu-Chi; Yeh, Fang-Yu; Lien, Ching-Feng; Chen, Chia-Chi; Cai, Bi-He

Serum Starvation-induced ROS Production Activates the ERK-AP-1-TfR1 Pathway to Up-regulate Survivin to Support Nasopharyngeal Carcinoma Cell Viability.

血清饥饿诱导的 ROS 产生激活 ERK-AP-1-TfR1 通路,上调 Survivin 以支持鼻咽癌细胞的存活

Wang Chih-Chun, Hwang Tzer-Zen, Lien Ching-Feng, Li Yingxiao, Lan Yu-Yan

Programmed Death Ligand-1 and Tumor Burden Score Dictate Treatment Responses in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

程序性死亡配体-1和肿瘤负荷评分决定复发或转移性头颈部鳞状细胞癌患者的治疗反应

Lien, Ming-Yu; Wang, Chih-Chun; Hwang, Tzer-Zen; Hsieh, Ching-Yun; Yang, Chuan-Chien; Wang, Chien-Chung; Lien, Ching-Feng; Shih, Yu-Chen; Yeh, Shyh-An; Hsieh, Meng-Che

Comparison of EMG amplitudes recorded by ipsilateral and contralateral electrodes placement during using trans-thyroid cartilage recording method in thyroid surgery

甲状腺手术中采用经甲状软骨记录法,比较同侧和对侧电极放置时记录的肌电图振幅。

Chiang, Feng-Yu; Shih, Yu-Chen; Lien, Ching-Feng; Wang, Chih-Chun; Wang, Chien-Chung; Hwang, Tzer-Zen; Huang, Yaw-Chang; Wu, Che-Wei; Yeh, Tai-Hung; Huang, Tzu-Yen

Impact of Parenteral Glutamine Supplement on Oncologic Outcomes in Patients with Nasopharyngeal Cancer Treated with Concurrent Chemoradiotherapy

肠外补充谷氨酰胺对接受同步放化疗的鼻咽癌患者肿瘤治疗结果的影响

Wang, Chih-Chun; Hwang, Tzer-Zen; Yang, Chuan-Chien; Lien, Ching-Feng; Wang, Chien-Chung; Shih, Yu-Chen; Yeh, Shyh-An; Hsieh, Meng-Che

Treatment Sequences in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Cetuximab Followed by Immunotherapy or Vice Versa

复发性或转移性头颈部鳞状细胞癌患者的治疗顺序:先使用西妥昔单抗,再使用免疫疗法,或反之亦然

Yang, Chuan-Chien; Lien, Ching-Feng; Hwang, Tzer-Zen; Wang, Chih-Chun; Wang, Chien-Chung; Shih, Yu-Chen; Yeh, Shyh-An; Hsieh, Meng-Che

P63 and P73 Activation in Cancers with p53 Mutation

p53突变癌症中的p63和p73激活

Cai, Bi-He; Hsu, Yun-Chien; Yeh, Fang-Yu; Lin, Yu-Rou; Lu, Rui-Yu; Yu, Si-Jie; Shaw, Jei-Fu; Wu, Ming-Han; Tsai, Yi-Zhen; Lin, Ying-Chen; Bai, Zhi-Yu; Shih, Yu-Chen; Hsu, Yi-Chiang; Liao, Ruo-Yu; Kuo, Wei-Hsin; Hsu, Chao-Tien; Lien, Ching-Feng; Chen, Chia-Chi

Tegafur-Uracil versus 5-Fluorouracil in Combination with Cisplatin and Cetuximab in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Analysis

替加氟-尿嘧啶联合顺铂和西妥昔单抗治疗老年复发或转移性头颈部鳞状细胞癌患者的疗效比较:一项倾向评分匹配分析

Hsieh, Meng-Che; Wang, Chih-Chun; Yang, Chuan-Chien; Lien, Ching-Feng; Wang, Chien-Chung; Shih, Yu-Chen; Yeh, Shyh-An; Hwang, Tzer-Zen